These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27670602)

  • 1. Biomarkers in Search of Precision Medicine in IBD.
    Boyapati RK; Kalla R; Satsangi J; Ho GT
    Am J Gastroenterol; 2016 Dec; 111(12):1682-1690. PubMed ID: 27670602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics.
    Voskuil MD; Bangma A; Weersma RK; Festen EAM
    World J Gastroenterol; 2019 Jun; 25(21):2539-2548. PubMed ID: 31210708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in IBD Research: Precision Medicine.
    Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
    Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big data in IBD: big progress for clinical practice.
    Seyed Tabib NS; Madgwick M; Sudhakar P; Verstockt B; Korcsmaros T; Vermeire S
    Gut; 2020 Aug; 69(8):1520-1532. PubMed ID: 32111636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future biologic targets for IBD: potentials and pitfalls.
    Melmed GY; Targan SR
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):110-7. PubMed ID: 20134493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1.
    Imhann F; Van der Velde KJ; Barbieri R; Alberts R; Voskuil MD; Vich Vila A; Collij V; Spekhorst LM; Van der Sloot KWJ; Peters V; Van Dullemen HM; Visschedijk MC; Festen EAM; Swertz MA; Dijkstra G; Weersma RK
    BMC Gastroenterol; 2019 Jan; 19(1):5. PubMed ID: 30621600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage analysis identifies novel genetic modifiers of microbiome traits in families with inflammatory bowel disease.
    Sharma A; Szymczak S; Rühlemann M; Freitag-Wolf S; Knecht C; Enderle J; Schreiber S; Franke A; Lieb W; Krawczak M; Dempfle A
    Gut Microbes; 2022; 14(1):2024415. PubMed ID: 35129060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease.
    Dubinsky MC; Mei L; Friedman M; Dhere T; Haritunians T; Hakonarson H; Kim C; Glessner J; Targan SR; McGovern DP; Taylor KD; Rotter JI
    Inflamm Bowel Dis; 2010 Aug; 16(8):1357-66. PubMed ID: 20014019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation in inflammatory bowel disease and beyond.
    Low D; Mizoguchi A; Mizoguchi E
    World J Gastroenterol; 2013 Aug; 19(32):5238-49. PubMed ID: 23983426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of inflammatory bowel disease.
    van den Bosch BJ; Coenen MJ
    Pharmacogenomics; 2021 Jan; 22(1):55-66. PubMed ID: 33305616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease.
    Wang Z; Guo K; Gao P; Pu Q; Lin P; Qin S; Xie N; Hur J; Li C; Huang C; Wu M
    Theranostics; 2021; 11(15):7491-7506. PubMed ID: 34158863
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
    Stylianou E
    Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology.
    Liu XY; Tang H; Zhou QY; Zeng YL; Chen D; Xu H; Li Y; Tan B; Qian JM
    World J Gastroenterol; 2023 Jan; 29(2):272-285. PubMed ID: 36687128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
    Quetglas EG; Mujagic Z; Wigge S; Keszthelyi D; Wachten S; Masclee A; Reinisch W
    World J Gastroenterol; 2015 Nov; 21(44):12519-43. PubMed ID: 26640330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of IBD Heritability: Genes, Bugs, and More.
    Turpin W; Goethel A; Bedrani L; Croitoru Mdcm K
    Inflamm Bowel Dis; 2018 May; 24(6):1133-1148. PubMed ID: 29701818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease.
    Meddens CA; Harakalova M; van den Dungen NA; Foroughi Asl H; Hijma HJ; Cuppen EP; Björkegren JL; Asselbergs FW; Nieuwenhuis EE; Mokry M
    Genome Biol; 2016 Nov; 17(1):247. PubMed ID: 27903283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status and Future Prospects of Inflammatory Bowel Disease Genetics.
    Kakuta Y; Naito T; Kinouchi Y; Masamune A
    Digestion; 2023; 104(1):7-15. PubMed ID: 36323245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of advances in genetics and pharmacogenetics of IBD.
    Ahmad T; Tamboli CP; Jewell D; Colombel JF
    Gastroenterology; 2004 May; 126(6):1533-49. PubMed ID: 15168365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.